US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. Read the full story

Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. Read the full story

EMD Serono has begun co-promoting Pfizer's anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer. Read the full story

23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer. Read the full story

India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story

Pfizer and Hospira have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, Read the full story

Pfizer issued to Repligen a notice of termination for convenience under the License Agreement, dated December 28, 2012 Read the full story

HemoShear announced a multi-year platform collaboration with Pfizer Read the full story

Pfizer has acquired a controlling interest in Redvax Read the full story